| 000 | 01394 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514161201.0 | ||
| 264 | 0 | _c20040603 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a1352-4585 | ||
| 024 | 7 |
_a10.1191/1352458503ms926oa _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPortaccio, E | |
| 245 | 0 | 0 |
_aSafety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort. _h[electronic resource] |
| 260 |
_bMultiple sclerosis (Houndmills, Basingstoke, England) _cOct 2003 |
||
| 300 |
_a446-50 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aPulse Therapy, Drug |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZipoli, V | |
| 700 | 1 | _aSiracusa, G | |
| 700 | 1 | _aPiacentini, S | |
| 700 | 1 | _aSorbi, S | |
| 700 | 1 | _aAmato, M P | |
| 773 | 0 |
_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 9 _gno. 5 _gp. 446-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1191/1352458503ms926oa _zAvailable from publisher's website |
| 999 |
_c14324247 _d14324247 |
||